| pubmed-article:20207772 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20207772 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:20207772 | lifeskim:mentions | umls-concept:C1883674 | lld:lifeskim |
| pubmed-article:20207772 | lifeskim:mentions | umls-concept:C0017428 | lld:lifeskim |
| pubmed-article:20207772 | lifeskim:mentions | umls-concept:C0032520 | lld:lifeskim |
| pubmed-article:20207772 | lifeskim:mentions | umls-concept:C1414313 | lld:lifeskim |
| pubmed-article:20207772 | lifeskim:mentions | umls-concept:C1510941 | lld:lifeskim |
| pubmed-article:20207772 | lifeskim:mentions | umls-concept:C1515926 | lld:lifeskim |
| pubmed-article:20207772 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:20207772 | pubmed:dateCreated | 2010-3-29 | lld:pubmed |
| pubmed-article:20207772 | pubmed:abstractText | The EGFR [epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)] gene is known to harbor genomic alterations in advanced lung cancer involving gene amplification and kinase mutations that predict the clinical response to EGFR-targeted inhibitors. Methods for detecting such molecular changes in lung cancer tumors are desirable. | lld:pubmed |
| pubmed-article:20207772 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20207772 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20207772 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20207772 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20207772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20207772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20207772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20207772 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20207772 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:20207772 | pubmed:issn | 1530-8561 | lld:pubmed |
| pubmed-article:20207772 | pubmed:author | pubmed-author:PonsB SBS | lld:pubmed |
| pubmed-article:20207772 | pubmed:author | pubmed-author:MaPatrick CPC | lld:pubmed |
| pubmed-article:20207772 | pubmed:author | pubmed-author:WangJunJ | lld:pubmed |
| pubmed-article:20207772 | pubmed:author | pubmed-author:RamakrishnanR... | lld:pubmed |
| pubmed-article:20207772 | pubmed:author | pubmed-author:DowlatiAfshin... | lld:pubmed |
| pubmed-article:20207772 | pubmed:author | pubmed-author:KlugeAmyA | lld:pubmed |
| pubmed-article:20207772 | pubmed:author | pubmed-author:JonesRobert... | lld:pubmed |
| pubmed-article:20207772 | pubmed:author | pubmed-author:FanWeiwenW | lld:pubmed |
| pubmed-article:20207772 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20207772 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:20207772 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20207772 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20207772 | pubmed:pagination | 623-32 | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:meshHeading | pubmed-meshheading:20207772... | lld:pubmed |
| pubmed-article:20207772 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20207772 | pubmed:articleTitle | Quantifying EGFR alterations in the lung cancer genome with nanofluidic digital PCR arrays. | lld:pubmed |
| pubmed-article:20207772 | pubmed:affiliation | Fluidigm Corporation, South San Francisco, CA, USA. | lld:pubmed |
| pubmed-article:20207772 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20207772 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20207772 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| entrez-gene:1956 | entrezgene:pubmed | pubmed-article:20207772 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20207772 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20207772 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20207772 | lld:pubmed |
